DiamiR Biosciences Corp. (DIMR)

DiamiR Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is June - May.

Year Ending	TTM	May 31, 2023	May 31, 2022
Net Income	-0.63	-1.32	-0.32
Depreciation & Amortization	0.04	0.09	0.12
Share-Based Compensation	-	0.97	0.13
Other Operating Activities	0.35	0.06	0.19
Operating Cash Flow	-0.24	-0.21	0.12
Capital Expenditures	-0	-	-0
Investing Cash Flow	-0	-	-0
Share Issuance / Repurchase	-	0.1	-
Financing Cash Flow	0.1	0.1	-
Net Cash Flow	-0.14	-0.11	0.12
Free Cash Flow	-0.24	-0.21	0.12
Free Cash Flow Margin	-18.34%	-18.38%	8.36%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).